Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma
5 clinical trials · Condition
◉ Watch Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma (NCT03422536) | University of Arizona | 2017-12-05 |
| Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer (NCT03032250) | Wake Forest University Health Sciences | 2017-05-15 |
| Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT02196168) | National Cancer Institute (NCI) | 2014-03-01 |
| Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385) | National Cancer Institute (NCI) | 2010-11-01 |
| Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery (NCT02007200) | National Cancer Institute (NCI) | 2009-07-01 |
Track Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.